Novartis Ag (NVS) Tax Rate (2009 - 2026)

Novartis Ag (NVS) posted Tax Rate of 23.71% for Q2 2026, up 111.86% sequentially from 11.19% in Q2 2025, and up 1252.0% YoY from 1.75% in Q2 2025.

Novartis Ag (NVS) Tax Rate (2009 - 2026) Analysis & Trends

Novartis Ag has reported Tax Rate for 12 years, with the latest figure at 23.71% in Q2 2026.

Quarterly Tax Rate rose 1252.0% year-over-year to 23.71% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 3.83% (up 361.0% YoY) and the FY2025 annual result came in at 14.59%, up 211.0% from the prior year.
Tax Rate rose to 23.71% in Q2 2026 per NVS's latest filing, from 11.19% in the prior quarter.
Over five years, Tax Rate peaked at 23.71% in Q2 2026 and troughed at 29.24% in Q3 2022.
A 5-year average of 8.27% and a median of 15.07% in 2023 frame the typical range for Tax Rate.
The sharpest annual moves came in 2022 and 2025: Tax Rate tumbled 173 bps in 2022, then jumped 2668 bps in 2025.
Over 5 years, Tax Rate stood at 18.55% in 2022, then advanced by 16 bps to 15.63% in 2023, then climbed by 5 bps to 14.86% in 2024, then surged by 175 bps to 11.19% in 2025, then jumped by 112 bps to 23.71% in 2026.
According to Business Quant data, Tax Rate over the past three periods registered 23.71%, 11.19%, and 14.86% for Q2 2026, Q2 2025, and Q4 2024 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Tax Rate (Qtr)
1	Johnson & Johnson	652.20 Bn	631.44 Bn	17.26 Bn	17.98%
2	AbbVie	469.51 Bn	462.94 Bn	12.70 Bn	15.47%
3	Merck	376.81 Bn	369.67 Bn	12.21 Bn	-95.75%
4	Novartis Ag	303.04 Bn	295.35 Bn	11.24 Bn	23.71%
5	Astrazeneca	257.61 Bn	252.71 Bn	12.86 Bn	10.40%
6	Amgen	237.37 Bn	223.38 Bn	7.24 Bn	14.20%
7	Gilead Sciences	181.73 Bn	178.55 Bn	6.22 Bn	-2.36%
8	Pfizer	159.66 Bn	147.96 Bn	10.94 Bn	62.33%
9	Gsk	106.24 Bn	102.07 Bn	8.24 Bn	56.21%
10	Sanofi	55.07 Bn	47.69 Bn	10.79 Bn	-3.05%

Download Data